CN Patent
CN101291658A — 用于制备稳定性增加的水难溶性药物的组合物和方法
Assigned to Abraxis Bioscience LLC · Expires 2008-10-22 · 18y expired
What this patent protects
本发明提供水难溶性药剂和稳定剂的稳定的药物组合物,所述稳定剂起增加组合物的稳定性的作用。在某些条件下,例如在稀释施用时,稳定剂的使用为水难溶性药剂如多西紫杉醇的纳米颗粒悬浮液和其它制剂提供延长的稳定性。
USPTO Abstract
本发明提供水难溶性药剂和稳定剂的稳定的药物组合物,所述稳定剂起增加组合物的稳定性的作用。在某些条件下,例如在稀释施用时,稳定剂的使用为水难溶性药剂如多西紫杉醇的纳米颗粒悬浮液和其它制剂提供延长的稳定性。
Drugs covered by this patent
- Rapamune (sirolimus) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.